| 摘要 |
FIELD: chemistry.SUBSTANCE: invention relates to a crystalline form of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine hydrochloride which is characterised by an X-ray powder diffraction profile having diffraction peaks at the following values of 2?: 4.44±0.20, 10.22±0.20, 17.16±0.20 and 21.78±0.20. The present invention also relates to a pharmaceutical composition containing a crystalline form of 4-[2-(2,4,6-trifluorophenoxymethyl)phenyl]piperidine hydrochloride and having norepinephrine and serotonin reuptake inhibitor action, methods of producing said crystalline salt and use of the crystalline salt to treat diseases, e.g., pain syndrome etc.EFFECT: novel crystalline form of a compound which can be used in treating a range of diseases is obtained and described.11 cl, 8 ex, 5 dwg |
